Back from ASH 2025, Dr Suchitra Sundaram reports on notable frontline CLL data. Time‑limited pirtobrutinib combined with venetoclax and obinutuzumab produced high rates of undetectable minimal ...
CLL is a type of leukemia where the bone marrow makes too many white blood cells. Treatment can help to slow the progression of the cancer and ease a person’s symptoms. CLL treatments include ...